Diagnostic methods for pancreatic cancer and their clinical applications (Review)
- Authors:
- Juan Zhao
- Jiahuan Wang
- Yuanlong Gu
- Xiaoyi Huang
- Linyou Wang
-
Affiliations: Daytime Treatment Center, Handan Central Hospital, Handan, Hebei 056000, P.R. China, Emergency Department, Municipal Hospital Affiliated to Taizhou University, Taizhou, Zhejiang 318000, P.R. China, Department of Interventional Oncology, Municipal Hospital Affiliated to Taizhou University, Taizhou, Zhejiang 318000, P.R. China, Biotherapy Center, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150000, P.R. China, Department of Radiology, Municipal Hospital Affiliated to Taizhou University, Taizhou, Zhejiang 318000, P.R. China - Published online on: May 27, 2025 https://doi.org/10.3892/ol.2025.15116
- Article Number: 370
-
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Siegel RL, Miller KD, Wagle NS and Jemal A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Huang C, Hecht EM, Soloff EV, Tiwari HA, Bhosale PR, Dasayam A, Galgano SJ, Kambadakone A, Kulkarni NM, Le O, et al: Imaging for early detection of pancreatic ductal adenocarcinoma: Updates and challenges in the implementation of screening and surveillance programs. AJR Am J Roentgenol. 223:e24311512024. View Article : Google Scholar : PubMed/NCBI | |
|
Blackford AL, Canto MI, Klein AP, Hruban RH and Goggins M: Recent trends in the incidence and survival of stage 1A pancreatic cancer: A surveillance, epidemiology, and end results analysis. J Natl Cancer Inst. 112:1162–1169. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Haberle L, Schramm M and Esposito I: Preoperative diagnostics of pancreatic neoplasms. Pathologe. 42:491–500. 2021.(In German). PubMed/NCBI | |
|
Bararia A, Chakraborty P, Roy P, Chattopadhay BK, Das A, Chatterjee A and Sikdar N: Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer. World J Gastroenterol. 29:2241–2260. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Schorr F and Essig MW: Early detection of pancreatic cancer - The role of endoscopic and transabdominal ultrasound. Z Gastroenterol. 59:1083–1090. 2021.(In German). PubMed/NCBI | |
|
Koziol-Bohatkiewicz P, Liberda-Matyja D and Wrobel TP: Fast cancer imaging in pancreatic biopsies using infrared imaging. Analyst. 149:1799–1806. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Zofia Rogowska A: Ultrasound-guided percutaneous core-needle biopsy of focal pancreatic lesions-practical aspectss. J Ultrason. 22:117–120. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Takahashi K, Takeda Y, Ono Y, Isomoto H and Mizukami Y: Current status of molecular diagnostic approaches using liquid biopsy. J Gastroenterol. 58:834–847. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Yang J, Xu R, Wang C, Qiu J, Ren B and You L: Early screening and diagnosis strategies of pancreatic cancer: A comprehensive review. Cancer Commun (Lond). 41:1257–1274. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Inchingolo R, Acquafredda F, Posa A, Nunes TF, Spiliopoulos S, Panzera F and Praticò CA: Endobiliary biopsy. World J Gastrointest Endosc. 14:291–301. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Navaneethan U, Spencer C, Zhu X, Vargo JJ, Grove D and Dweik RA: Volatile organic compounds in bile can distinguish pancreatic cancer from chronic pancreatitis: A prospective observational study. Endoscopy. 53:732–736. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Martinez-Moral MP, Tena MT, Martin-Carnicero A and Martinez A: Highly sensitive serum volatolomic biomarkers for pancreatic cancer diagnosis. Clin Chim Acta. 557:1178952024. View Article : Google Scholar : PubMed/NCBI | |
|
Daulton E, Wicaksono AN, Tiele A, Kocher HM, Debernardi S, Crnogorac-Jurcevic T and Covington JA: Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine. Talanta. 221:1216042021. View Article : Google Scholar : PubMed/NCBI | |
|
Ma X, He C, Wang Y, Cao X, Jin Z, Ge Y, Cao Z, An M and Hao L: Mechanisms and applications of manganese-based nanomaterials in tumor diagnosis and therapy. Biomater Res. 29:01582025. View Article : Google Scholar : PubMed/NCBI | |
|
Hu X, Wang Z, Zhu Y, Li Z, Yan H, Zhao X and Wang Q: Advancements in molecular imaging for the diagnosis and treatment of pancreatic ductal adenocarcinoma. Nanoscale Adv. Apr 22–2025.(Epub ahead of print). View Article : Google Scholar | |
|
Sijithra PC, Santhi N and Ramasamy N: A review study on early detection of pancreatic ductal adenocarcinoma using artificial intelligence assisted diagnostic methods. Eur J Radiol. 166:1109722023. View Article : Google Scholar : PubMed/NCBI | |
|
Nakahodo J, Kikuyama M, Nojiri S, Chiba K, Yoshimoto K, Kamisawa T, Horiguchi SI and Honda G: Focal parenchymal atrophy of pancreas: An important sign of underlying high-grade pancreatic intraepithelial neoplasia without invasive carcinoma, i.e., carcinoma in situ. Pancreatology. 20:1689–1697. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yamao K, Takenaka M, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Omoto S, Kamata K, Minaga K, Matsumoto I, et al: Partial pancreatic parenchymal atrophy is a new specific finding to diagnose small pancreatic cancer (</=10 mm) including carcinoma in situ: Comparison with localized benign main pancreatic duct stenosis patients. Diagnostics (Basel). 10:4452020. View Article : Google Scholar : PubMed/NCBI | |
|
Kanno A, Masamune A, Hanada K, Maguchi H, Shimizu Y, Ueki T, Hasebe O, Ohtsuka T, Nakamura M, Takenaka M, et al: Multicenter study of early pancreatic cancer in Japan. Pancreatology. 18:61–67. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kono Y, Oishi T, Ueda Y, Matsuoka E, Kamimura R, Tokiyoshi T, Okamoto T and Kashima S: A surgically resected case of lung metastases and sister Mary Joseph's Nodule 24 months after operation for pancreatic cancer. Gan To Kagaku Ryoho. 46:2354–2356. 2019.(In Japanese). PubMed/NCBI | |
|
Jia WY, Gui Y, Chen XQ, Tan L, Zhang J, Xiao MS, Chang XY, Dai MH, Guo JC, Cheng YJ, et al: Efficacy of color Doppler ultrasound and contrast-enhanced ultrasound in identifying vascular invasion in pancreatic ductal adenocarcinoma. Insights Imaging. 15:1812024. View Article : Google Scholar : PubMed/NCBI | |
|
Bonde A, Smith DA, Kikano E, Yoest JM, Tirumani SH and Ramaiya NH: Overview of serum and tissue markers in colorectal cancer: A primer for radiologists. Abdom Radiol (NY). 46:5521–5535. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou D, Mu D, Cheng M, Dou Y, Zhang X, Feng Z, Qiu G, Yu H, Chen Y, Xu H, et al: Differences in lipidomics may be potential biomarkers for early diagnosis of pancreatic cancer. Acta Cir Bras. 35:e2020005082020. View Article : Google Scholar : PubMed/NCBI | |
|
Boyd LNC, Ali M, Comandatore A, Garajova I, Kam L, Puik JR, Fraga Rodrigues SM, Meijer LL, Le Large TYS, Besselink MG, et al: Prediction model for early-stage pancreatic cancer using routinely measured blood biomarkers. JAMA Netw Open. 6:e23311972023. View Article : Google Scholar : PubMed/NCBI | |
|
Guo W, Ying P, Ma R, Jing Z, Ma G, Long J, Li G and Liu Z: Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer. Cytokine Growth Factor Rev. 73:69–77. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Dahiya DS, Shah YR, Ali H, Chandan S, Gangwani MK, Canakis A, Ramai D, Hayat U, Pinnam BSM, Iqbal A, et al: Basic principles and role of endoscopic ultrasound in diagnosis and differentiation of pancreatic cancer from other pancreatic lesions: A comprehensive review of endoscopic ultrasound for pancreatic cancer. J Clin Med. 13:25992024. View Article : Google Scholar : PubMed/NCBI | |
|
Park JM, Mau CZ, Chen YC, Su YH, Chen HA, Huang SY, Chang JS and Chiu CF: A case-control study in Taiwanese cohort and meta-analysis of serum ferritin in pancreatic cancer. Sci Rep. 11:212422021. View Article : Google Scholar : PubMed/NCBI | |
|
Dias ESD and Chung V: Neoadjuvant treatment for pancreatic cancer: Controversies and advances. Cancer Treat Res Commun. 39:1008042024. View Article : Google Scholar : PubMed/NCBI | |
|
Roehnisch T, Martos-Contreras MC, Manoochehri M, Nogueira M, Bremm F, Dörrie J, Christoph J, Kunz M and Schönharting W: Individualized neoantigen peptide immunization of a metastatic pancreatic cancer patient: A case report of combined tumor and liquid biopsy. Front Immunol. 15:14147372024. View Article : Google Scholar : PubMed/NCBI | |
|
Singhi AD, Koay EJ, Chari ST and Maitra A: Early detection of pancreatic cancer: Opportunities and challenges. Gastroenterology. 156:2024–2040. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ishikawa-Kakiya Y, Maruyama H, Kinoshita Y, Hayashi K, Yamamura M, Tanoue K, Nagami Y, Tanigawa T, Watanabe T and Fujiwara Y: The usefulness of serial pancreatic juice aspiration cytological examination for pancreatic cancer not diagnosed by EUS-FNAB. Clin J Gastroenterol. 13:1367–1372. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Chalfant H, Bonds M, Scott K, Condacse A, Dennahy IS, Martin WT, Little C, Edil BH, McNally LR and Jain A: Innovative imaging techniques used to evaluate borderline-resectable pancreatic adenocarcinoma. J Surg Res. 284:42–53. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Tantau A, Leucuta DC, Tantau M, Boţan E, Zaharie R, Mândruţiu A and Tomuleasa IC: Inflammation, tumoral markers and interleukin-17, −10, and −6 profiles in pancreatic adenocarcinoma and chronic pancreatitis. Dig Dis Sci. 66:3427–3438. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wiest NE, Moktan VP, Oman SP and Chirila RM: Screening for pancreatic cancer: A review for general clinicians. Rom J Intern Med. 58:119–128. 2020.PubMed/NCBI | |
|
Granata V, Fusco R, Setola SV, Galdiero R, Maggialetti N, Silvestro L, De Bellis M, Di Girolamo E, Grazzini G, Chiti G, et al: Risk assessment and pancreatic cancer: Diagnostic management and artificial intelligence. Cancers (Basel). 15:3512023. View Article : Google Scholar : PubMed/NCBI | |
|
Chu LC and Fishman EK: Pancreatic ductal adenocarcinoma staging: A narrative review of radiologic techniques and advances. Int J Surg. 110:6052–6063. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Koh DM, Papanikolaou N, Bick U, Illing R, Kahn CE Jr, Kalpathi-Cramer J, Matos C, Martí-Bonmatí L, Miles A, Mun SK, et al: Artificial intelligence and machine learning in cancer imaging. Commun Med (Lond). 2:1332022. View Article : Google Scholar : PubMed/NCBI | |
|
Mukund A, Afridi MA, Karolak A, Park MA, Permuth JB and Rasool G: Pancreatic ductal adenocarcinoma (PDAC): A review of recent advancements enabled by artificial intelligence. Cancers (Basel). 16:22402024. View Article : Google Scholar : PubMed/NCBI | |
|
Udristoiu AL, Cazacu IM, Gruionu LG, Gruionu G, Iacob AV, Burtea DE, Ungureanu BS, Costache MI, Constantin A, Popescu CF, et al: Real-time computer-aided diagnosis of focal pancreatic masses from endoscopic ultrasound imaging based on a hybrid convolutional and long short-term memory neural network model. PLoS One. 16:e02517012021. View Article : Google Scholar : PubMed/NCBI | |
|
Tong T, Gu J, Xu D, Song L, Zhao Q, Cheng F, Yuan Z, Tian S, Yang X, Tian J, et al: Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis. BMC Med. 20:742022. View Article : Google Scholar : PubMed/NCBI | |
|
Tonozuka R, Itoi T, Nagata N, Kojima H, Sofuni A, Tsuchiya T, Ishii K, Tanaka R, Nagakawa Y and Mukai S: Deep learning analysis for the detection of pancreatic cancer on endosonographic images: A pilot study. J Hepatobiliary Pancreat Sci. 28:95–104. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Marya NB, Powers PD, Chari ST, Gleeson FC, Leggett CL, Abu Dayyeh BK, Chandrasekhara V, Iyer PG, Majumder S, Pearson RK, et al: Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis. Gut. 70:1335–1344. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Kuwahara T, Hara K, Mizuno N, Haba S, Okuno N, Kuraishi Y, Fumihara D, Yanaidani T, Ishikawa S, Yasuda T, et al: Artificial intelligence using deep learning analysis of endoscopic ultrasonography images for the differential diagnosis of pancreatic masses. Endoscopy. 55:140–149. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Ma H, Liu ZX, Zhang JJ, Wu FT, Xu CF, Shen Z, Yu CH and Li YM: Construction of a convolutional neural network classifier developed by computed tomography images for pancreatic cancer diagnosis. World J Gastroenterol. 26:5156–5168. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu SL, Li S, Guo YT, Zhou YP, Zhang ZD, Li S and Lu Y: Establishment and application of an artificial intelligence diagnosis system for pancreatic cancer with a faster region-based convolutional neural network. Chin Med J (Engl). 132:2795–2803. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Si K, Xue Y, Yu X, Zhu X, Li Q, Gong W, Liang T and Duan S: Fully end-to-end deep-learning-based diagnosis of pancreatic tumors. Theranostics. 11:1982–1990. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Qiu JJ, Yin J, Qian W, Liu JH, Huang ZX, Yu HP, Ji L and Zeng XX: A novel multiresolution-statistical texture analysis architecture: Radiomics-aided diagnosis of PDAC based on plain CT images. IEEE Trans Med Imaging. 40:12–25. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Qureshi TA, Gaddam S, Wachsman AM, Wang L, Azab L, Asadpour V, Chen W, Xie Y, Wu B, Pandol SJ and Li D: Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images. Cancer Biomark. 33:211–217. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Ebrahimian S, Singh R, Netaji A, Madhusudhan KS, Homayounieh F, Primak A, Lades F, Saini S, Kalra MK and Sharma S: Characterization of benign and malignant pancreatic lesions with DECT quantitative metrics and radiomics. Acad Radiol. 29:705–713. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Chu LC, Park S, Kawamoto S, Fouladi DF, Shayesteh S, Zinreich ES, Graves JS, Horton KM, Hruban RH, Yuille AL, et al: Utility of CT radiomics features in differentiation of pancreatic ductal adenocarcinoma from normal pancreatic tissue. AJR Am J Roentgenol. 213:349–357. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Mukherjee S, Patra A, Khasawneh H, Korfiatis P, Rajamohan N, Suman G, Majumder S, Panda A, Johnson MP, Larson NB, et al: Radiomics-based machine-learning models can detect pancreatic cancer on prediagnostic computed tomography scans at a substantial lead time before clinical diagnosis. Gastroenterology. 163:1435–1446. e32022. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Liu F, Fang X, Cao K, Meng Y, Zhang H, Yu J, Feng X, Li Q, Liu Y, et al: CT radiomics features in differentiation of focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A propensity score analysis. Acad Radiol. 29:358–366. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Ziegelmayer S, Kaissis G, Harder F, Jungmann F, Müller T, Makowski M and Braren R: Deep convolutional neural network-assisted feature extraction for diagnostic discrimination and feature visualization in pancreatic ductal adenocarcinoma (PDAC) versus autoimmune pancreatitis (AIP). J Clin Med. 9:40132020. View Article : Google Scholar : PubMed/NCBI | |
|
Cao K, Xia Y, Yao J, Han X, Lambert L, Zhang T, Tang W, Jin G, Jiang H, Fang X, et al: Large-scale pancreatic cancer detection via non-contrast CT and deep learning. Nat Med. 29:3033–3043. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Chen PT, Wu T, Wang P, Chang D, Liu KL, Wu MS, Roth HR, Lee PC, Liao WC and Wang W: pancreatic cancer detection on ct scans with deep learning: A nationwide population-based study. Radiology. 306:172–182. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Tayebi Arasteh S, Ziller A, Kuhl C, Makowski M, Nebelung S, Braren R, Rueckert D, Truhn D and Kaissis G: Preserving fairness and diagnostic accuracy in private large-scale AI models for medical imaging. Commun Med (Lond). 4:462024. View Article : Google Scholar : PubMed/NCBI | |
|
Liang Y, Schott D, Zhang Y, Wang Z, Nasief H, Paulson E, Hall W, Knechtges P, Erickson B and Li XA: Auto-segmentation of pancreatic tumor in multi-parametric MRI using deep convolutional neural networks. Radiother Oncol. 145:193–200. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Feng C, Lin X and Qian X: Utilizing GCN and meta-learning strategy in unsupervised domain adaptation for pancreatic cancer segmentation. IEEE J Biomed Health Inform. 26:79–89. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Chen Z, Li J, Zhang YD, Lin X and Qian X: Model-driven deep learning method for pancreatic cancer segmentation based on spiral-transformation. IEEE Trans Med Imaging. 41:75–87. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Jiang H, Wang Z, Zhang G and Yao YD: An effective computer aided diagnosis model for pancreas cancer on PET/CT images. Comput Methods Programs Biomed. 165:205–214. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Z, Li M, Zuo C, Yang Z and Yang X, Ren S, Peng Y, Sun G, Shen J, Cheng C and Yang X: Radiomics model of dual-time 2-[(18)F]FDG PET/CT imaging to distinguish between pancreatic ductal adenocarcinoma and autoimmune pancreatitis. Eur Radiol. 31:6983–6991. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Cheng C, Liu Z, Wang L, Pan G, Sun G, Chang Y, Zuo C and Yang X: Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in (18) F-FDG PET/CT. Med Phys. 46:4520–4530. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yu H, Zhang C, Liu S, Jiang G, Li S, Zhang L, Wang Y and Xu W: Clinical value of CT-guided percutaneous fine-needle aspiration biopsy for peritoneal lesions. BMC Med Imaging. 20:1222020. View Article : Google Scholar : PubMed/NCBI | |
|
Lee JH, Kim H, Lee SH, Ku JL, Chun JW, Seo HY, Kim SC, Paik WH, Ryu JK, Lee SK, et al: Establishment of patient-derived pancreatic cancer organoids from endoscopic ultrasound-guided fine-needle aspiration biopsies. Gut Liver. 16:625–636. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Masuda H, Kotecha K, Maitra R, Gill AJ, Mittal A and Samra JS: Clinical suspicion of pancreatic cancer despite negative endoscopic ultrasound-guided fine-needle aspiration biopsy. ANZ J Surg. 92:99–108. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Abe I and Lam AK: Fine-needle aspiration under guidance of ultrasound examination of thyroid lesions. Methods Mol Biol. 2534:29–37. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Smetanina SV, Slavnova EN, Smetanina OV, Golovin ST and Eremin NV: Features of differential cytological diagnosis of primary and metastatic liver carcinoma. Klin Lab Diagn. 66:364–370. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Taniuchi K, Ueno M, Yokose T, Sakaguchi M, Yoshioka R, Ogasawara M, Kosaki T, Naganuma S and Furihata M: Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients. PLoS One. 17:e02651722022. View Article : Google Scholar : PubMed/NCBI | |
|
Mason J, Lundberg E, Jonsson P, Nyström H, Franklin O, Lundin C, Naredi P, Antti H, Sund M and Öhlund D: A cross-sectional and longitudinal analysis of pre-diagnostic blood plasma biomarkers for early detection of pancreatic cancer. Int J Mol Sci. 23:129692022. View Article : Google Scholar : PubMed/NCBI | |
|
Pietri E, Balsano R, Coriano M, Gelsomino F, Leonardi F, Bui S, Gnetti L, Valle RD and Garajová I: The implication of liquid biopsies to predict chemoresistance in pancreatic cancer. Cancer Drug Resist. 4:559–572. 2021.PubMed/NCBI | |
|
Gu YL, Lan C, Pei H, Yang SN, Liu YF and Xiao LL: Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in diagnosis and prognosis for patients with pancreatic cancer treated by concurrent chemoradiotherapy. Asian Pac J Cancer Prev. 16:6569–6573. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Wang Y, Zhao T, Li Y, Tian L, Zhao J and Zhang J: Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer. World J Surg Oncol. 18:312020. View Article : Google Scholar : PubMed/NCBI | |
|
Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, et al: Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. EBioMedicine. 42:375–385. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Aronsson L, Andersson R, Bauden M, Andersson B, Bygott T and Ansari D: High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm. Scand J Gastroenterol. 53:1597–1603. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Wang Q and Wang R: Roles of exosome genomic DNA in colorectal cancer. Front Pharmacol. 13:9232322022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang ZY, Wang RX, Ding XQ, Zhang X, Pan XR and Tong JH: A protocol for cancer-related mutation detection on exosomal DNA in clinical application. Front Oncol. 10:5581062020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Y, Zhang H, Chen N, Hao J, Jin H and Ma X: Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis. Medicine (Baltimore). 99:e185812020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Z, Zhang Y, Zhang W, Tang D, Zhang S, Wang L, Zou X, Ni Z, Zhang S, Lv Y and Xiang N: High-throughput enrichment of portal venous circulating tumor cells for highly sensitive diagnosis of CA19-9-negative pancreatic cancer patients using inertial microfluidics. Biosens Bioelectron. 259:1164112024. View Article : Google Scholar : PubMed/NCBI | |
|
Chen M, Liu H, Xiao Y, Liang R, Xu H, Hong B and Qian Y: Predictive biomarkers of pancreatic cancer metastasis: A comprehensive review. Clin Chim Acta. 569:1201762025. View Article : Google Scholar : PubMed/NCBI | |
|
Luo K, Wang X, Zhang X, Liu Z, Huang S and Li R: The value of circulating tumor cells in the prognosis and treatment of pancreatic cancer. Front Oncol. 12:9336452022. View Article : Google Scholar : PubMed/NCBI | |
|
Cui Y and Cao M: Liquid biopsy in bladder cancer. Methods Mol Biol. 2695:111–120. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Nagai M, Sho M, Akahori T, Nakagawa K and Nakamura K: Application of liquid biopsy for surgical management of pancreatic cancer. Ann Gastroenterol Surg. 4:216–223. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Gu X, Wei S and Lv X: Circulating tumor cells: From new biological insights to clinical practice. Signal Transduct Target Ther. 9:2262024. View Article : Google Scholar : PubMed/NCBI | |
|
Antonarakis ES, Lu C, Luber B, Wang H, Chen Y, Zhu Y, Silberstein JL, Taylor MN, Maughan BL, Denmeade SR, et al: Clinical significance of androgen receptor splice variant-7 mRNA detection in circulating tumor cells of men with metastatic castration-resistant prostate cancer treated with first- and second-line abiraterone and enzalutamide. J Clin Oncol. 35:2149–2156. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Silva ATF, Rodrigues CM, Ferreira ICC, Santos LLD, Santos DW, Araújo TG, Canto PPL, Paiva CE, Goulart LR and Maia YCP: A novel detection method of breast cancer through a simple panel of biomarkers. Int J Mol Sci. 23:119832022. View Article : Google Scholar : PubMed/NCBI | |
|
Earl J, Garcia-Nieto S, Martinez-Avila JC, Montans J, Sanjuanbenito A, Rodríguez-Garrote M, Lisa E, Mendía E, Lobo E, Malats N, et al: Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer. BMC Cancer. 15:7972015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang ZH, Bao YW, Zhao YJ, Wang JQ, Guo JT and Sun SY: Circulating tumor cells as potential prognostic biomarkers for early-stage pancreatic cancer: A systematic review and meta-analysis. World J Clin Oncol. 14:504–517. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Ankeny JS, Court CM, Hou S, Li Q, Song M, Wu D, Chen JF, Lee T, Lin M, Sho S, et al: Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer. Br J Cancer. 114:1367–1375. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bidard FC, Huguet F, Louvet C, Mineur L, Bouché O, Chibaudel B, Artru P, Desseigne F, Bachet JB, Mathiot C, et al: Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol. 24:2057–2061. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tien YW, Kuo HC, Ho BI, Chang MC, Chang YT, Cheng MF, Chen HL, Liang TY, Wang CF, Huang CY, et al: A high circulating tumor cell count in portal vein predicts liver metastasis from periampullary or pancreatic cancer: A high portal venous CTC count predicts liver metastases. Medicine (Baltimore). 95:e34072016. View Article : Google Scholar : PubMed/NCBI | |
|
Ahrens TD, Bang-Christensen SR, Jorgensen AM, Løppke C, Spliid CB, Sand NT, Clausen TM, Salanti A and Agerbæk MØ: The role of proteoglycans in cancer metastasis and circulating tumor cell analysis. Front Cell Dev Biol. 8:7492020. View Article : Google Scholar : PubMed/NCBI | |
|
Koo B, Jun E, Liu H, Kim EJ, Park YY, Lim SB, Kim SC and Shin Y: A biocomposite-based rapid sampling assay for circulating cell-free DNA in liquid biopsy samples from human cancers. Sci Rep. 10:149322020. View Article : Google Scholar : PubMed/NCBI | |
|
Bi F, Wang Q, Dong Q, Wang Y, Zhang L and Zhang J: Circulating tumor DNA in colorectal cancer: opportunities and challenges. Am J Transl Res. 12:1044–1055. 2020.PubMed/NCBI | |
|
Gai W and Sun K: Epigenetic biomarkers in cell-free DNA and applications in liquid biopsy. Genes (Basel). 10:322019. View Article : Google Scholar : PubMed/NCBI | |
|
Oliveira KCS, Ramos IB, Silva JMC, Barra WF, Riggins GJ, Palande V, Pinho CT, Frenkel-Morgenstern M, Santos SEB, Assumpcao PP, et al: Current perspectives on circulating tumor DNA, precision medicine, and personalized clinical management of cancer. Mol Cancer Res. 18:517–528. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Cescon DW, Bratman SV, Chan SM and Siu LL: Circulating tumor DNA and liquid biopsy in oncology. Nat Cancer. 1:276–290. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Topham JT, Renouf DJ and Schaeffer DF: Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma. Ther Adv Med Oncol. 15:175883592311576512023. View Article : Google Scholar : PubMed/NCBI | |
|
Zill OA, Greene C, Sebisanovic D, Siew LM, Leng J, Vu M, Hendifar AE, Wang Z, Atreya CE, Kelley RK, et al: Cell-Free DNA next-generation sequencing in pancreatobiliary carcinomas. Cancer Discov. 5:1040–1048. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Di Y, Li J, Jiang Y, He H, Yao L, Gu J, Lu J, Song J, Chen S, et al: Blood-based genomic profiling of circulating tumor DNA from patients with advanced pancreatic cancer and its value to guide clinical treatment. J Cancer. 11:4316–4323. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Wang L, Zhao Q, Wang Z, Lu S, Kang Y, Jin G and Tian J: Genome-wide analysis of cell-free DNA methylation profiling for the early diagnosis of pancreatic cancer. Front Genet. 11:5960782020. View Article : Google Scholar : PubMed/NCBI | |
|
Eissa MAL, Lerner L, Abdelfatah E, Shankar N, Canner JK, Hasan NM, Yaghoobi V, Huang B, Kerner Z, Takaesu F, et al: Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood. Clin Epigenetics. 11:592019. View Article : Google Scholar : PubMed/NCBI | |
|
Hu Q, Chen L, Li K, Liu R, Sun L and Han T: Circulating tumor DNA: Current implementation issues and future challenges for clinical utility. Clin Chem Lab Med. 62:2094–2110. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Słotwiński R and Slotwinska SM: Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. Cent Eur J Immunol. 41:392–403. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z: Diagnostic performance for declined microRNA-133a in pancreatic cancer. J Cell Biochem. 121:3882–3886. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wei J, Yang L, Wu YN and Xu J: Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer. J Cancer. 11:1325–1333. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kopcho S, McDew-White M, Naushad W, Mohan M and Okeoma CM: SIV Infection regulates compartmentalization of circulating blood plasma mirnas within extracellular vesicles (EVs) and extracellular condensates (ECs) and decreases EV-Associated miRNA-128. Viruses. 15:6222023. View Article : Google Scholar : PubMed/NCBI | |
|
Qin C, Li T, Lin C, Zhao B, Li Z, Zhao Y and Wang W: The systematic role of pancreatic cancer exosomes: Distant communication, liquid biopsy and future therapy. Cancer Cell Int. 24:2642024. View Article : Google Scholar : PubMed/NCBI | |
|
Zou X, Wei J, Huang Z, Zhou X, Lu Z, Zhu W and Miao Y: Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Cancer Med. 8:2810–2822. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou X, Lu Z, Wang T, Huang Z, Zhu W and Miao Y: Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Gene. 673:181–193. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Goto T, Fujiya M, Konishi H, Sasajima J, Fujibayashi S, Hayashi A, Utsumi T, Sato H, Iwama T, Ijiri M, et al: An elevated expression of serum exosomal microRNA-191, −21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker. BMC Cancer. 18:1162018. View Article : Google Scholar : PubMed/NCBI | |
|
Pu X, Ding G, Wu M, Zhou S, Jia S and Cao L: Elevated expression of exosomal microRNA-21 as a potential biomarker for the early diagnosis of pancreatic cancer using a tethered cationic lipoplex nanoparticle biochip. Oncol Lett. 19:2062–2070. 2020.PubMed/NCBI | |
|
Machida T, Tomofuji T, Maruyama T, Yoneda T, Ekuni D, Azuma T, Miyai H, Mizuno H, Kato H, Tsutsumi K, et al: miR-1246 and miR-4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer. Oncol Rep. 36:2375–2381. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshizawa N, Sugimoto K, Tameda M, Inagaki Y, Ikejiri M, Inoue H, Usui M, Ito M and Takei Y: miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma. Oncol Lett. 19:2677–2684. 2020.PubMed/NCBI | |
|
Shao H, Zhang Y, Yan J, Ban X, Fan X, Chang X, Lu Z, Wu Y, Zong L, Mo S, et al: Upregulated MicroRNA-483-3p is an early event in pancreatic ductal adenocarcinoma (PDAC) and as a powerful liquid biopsy biomarker in PDAC. Onco Targets Ther. 14:2163–2175. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang C, Wang J, Cui W, Liu Y, Zhou H, Wang Y, Chen X, Chen X and Wang Z: Serum Exosomal miRNA-1226 as potential biomarker of pancreatic ductal adenocarcinoma. Onco Targets Ther. 14:1441–1451. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Nakamura S, Sadakari Y, Ohtsuka T, Okayama T, Nakashima Y, Gotoh Y, Saeki K, Mori Y, Nakata K, Miyasaka Y, et al: Pancreatic juice exosomal MicroRNAs as biomarkers for detection of pancreatic ductal adenocarcinoma. Ann Surg Oncol. 26:2104–2111. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen J, Yao D, Chen W, Li Z, Guo Y, Zhu F and Hu X: Serum exosomal miR-451a acts as a candidate marker for pancreatic cancer. Int J Biol Markers. 37:74–80. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Wu J, Ye N, Li F, Zhan H, Chen S and Xu J: Plasma-derived exosome MiR-19b acts as a diagnostic marker for pancreatic cancer. Front Oncol. 11:7391112021. View Article : Google Scholar : PubMed/NCBI | |
|
Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, Nishiwada S, Sharma G, Cridebring D, Zenhausern F, et al: An Exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: A multicenter cohort study. Gastroenterology. 163:1252–1266. e22022. View Article : Google Scholar : PubMed/NCBI | |
|
Guo S, Qin H, Liu K, Wang H, Bai S, Liu S, Shao Z, Zhang Y, Song B, Xu X, et al: Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Clin Transl Med. 11:e5202021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen J, Zhang X, Zhang G, Zhu F and Liu W: Serum-derived exosomal miR-7977 combined with miR-451a as a potential biomarker for pancreatic ductal adenocarcinoma. BMC Cancer. 25:2952025. View Article : Google Scholar : PubMed/NCBI | |
|
Taniguchi T, Ideno N, Araki T, Miura S, Yamamoto M, Nakafusa T, Higashijima N, Yamamoto T, Tamura K, Nakamura S, et al: MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenocarcinoma. DEN Open. 4:e3332024. View Article : Google Scholar : PubMed/NCBI | |
|
Takahashi K, Ota Y, Kogure T, Suzuki Y, Iwamoto H, Yamakita K, Kitano Y, Fujii S, Haneda M, Patel T and Ota T: Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer. Cancer Sci. 111:98–111. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar SR, Kimchi ET, Manjunath Y, Gajagowni S, Stuckel AJ and Kaifi JT: Author Correction: RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions. Sci Rep. 10:99812020. View Article : Google Scholar : PubMed/NCBI | |
|
Yu S, Li Y, Liao Z, Wang Z, Li Y, Qian L, Zhao J, Zong H, Kang B, Zou WB, et al: Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma. Gut. 69:540–550. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Li Z, Jiang P, Peng M, Zhang X, Chen K, Liu H, Bi H, Liu X and Li X: Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis. J Exp Clin Cancer Res. 37:1772018. View Article : Google Scholar : PubMed/NCBI | |
|
Hong L, Xu L, Jin L, Xu K, Tang W, Zhu Y, Qiu X and Wang J: Exosomal circular RNA hsa_circ_0006220, and hsa_circ_0001666 as biomarkers in the diagnosis of pancreatic cancer. J Clin Lab Anal. 36:e244472022. View Article : Google Scholar : PubMed/NCBI | |
|
Kitagawa T, Taniuchi K, Tsuboi M, Sakaguchi M, Kohsaki T, Okabayashi T and Saibara T: Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer. Mol Oncol. 13:212–227. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hu J, Sheng Y, Kwak KJ, Shi J, Yu B and Lee LJ: A signal-amplifiable biochip quantifies extracellular vesicle-associated RNAs for early cancer detection. Nat Commun. 8:16832017. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Z, LaRiviere MJ, Ko J, Till JE, Christensen T, Yee SS, Black TA, Tien K, Lin A, Shen H, et al: A multianalyte panel consisting of extracellular vesicle miRNAs and mRNAs, cfDNA, and CA19-9 shows utility for diagnosis and staging of pancreatic ductal adenocarcinoma. Clin Cancer Res. 26:3248–3258. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar SR, Kimchi ET, Manjunath Y, Gajagowni S, Stuckel AJ and Kaifi JT: RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions. Sci Rep. 10:28002020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang F, Wang C, Chen S, Wei C, Ji J, Liu Y, Liang L, Chen Y, Li X, Zhao L, et al: Identification of blood-derived exosomal tumor RNA signatures as noninvasive diagnostic biomarkers for multi-cancer: A multi-phase, multi-center study. Mol Cancer. 24:602025. View Article : Google Scholar : PubMed/NCBI | |
|
Allenson K, Castillo J, San Lucas FA, Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ, et al: High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Ann Oncol. 28:741–747. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Castillo J, Bernard V, San Lucas FA, Allenson K, Capello M, Kim DU, Gascoyne P, Mulu FC, Stephens BM, Huang J, et al: Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann Oncol. 29:223–229. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Jin H, Liu P, Wu Y, Meng X, Wu M, Han J and Tan X: Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer. Cancer Sci. 109:2946–2956. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, et al: Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 523:177–182. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao D, Dong Z, Zhen L, Xia G, Huang X, Wang T, Guo H, Yang B, Xu C, Wu W, et al: Combined exosomal GPC1, CD82, and Serum CA19-9 as multiplex targets: A specific, sensitive, and reproducible detection panel for the diagnosis of pancreatic cancer. Mol Cancer Res. 18:300–310. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang KS, Im H, Hong S, Pergolini I, Del Castillo AF, Wang R, Clardy S, Huang CH, Pille C, Ferrone S, et al: Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy. Sci Transl Med. 9:eaal32262017. View Article : Google Scholar : PubMed/NCBI | |
|
Yang J, Zhang Y, Gao X, Yuan Y, Zhao J, Zhou S, Wang H, Wang L, Xu G, Li X, et al: Plasma-derived exosomal ALIX as a novel biomarker for diagnosis and classification of pancreatic cancer. Front Oncol. 11:6283462021. View Article : Google Scholar : PubMed/NCBI | |
|
Wei Q, Zhang J, Li Z, Wei L and Ren L: Serum Exo-EphA2 as a potential diagnostic biomarker for pancreatic cancer. Pancreas. 49:1213–1219. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liang K, Liu F, Fan J, Sun D, Liu C, Lyon CJ, Bernard DW, Li Y, Yokoi K, Katz MH, et al: Nanoplasmonic quantification of tumor-derived extracellular vesicles in plasma microsamples for diagnosis and treatment monitoring. Nat Biomed Eng. 1:002112017 View Article : Google Scholar : PubMed/NCBI | |
|
Shin HS, Jung SB, Park S, Dua P and Lee DK: ALPPL2 Is a potential diagnostic biomarker for pancreatic cancer-derived extracellular vesicles. Mol Ther Methods Clin Dev. 15:204–210. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lux A, Kahlert C, Grutzmann R and Pilarsky C: c-Met and PD-L1 on circulating exosomes as diagnostic and prognostic markers for pancreatic cancer. Int J Mol Sci. 20:33052019. View Article : Google Scholar : PubMed/NCBI | |
|
David P, Kouhestani D, Hansen FJ, Paul S, Czubayko F, Karabiber A, Weisel N, Klösch B, Merkel S, Ole-Baur J, et al: Exosomal CD40, CD25, and Serum CA19-9 as combinatory novel liquid biopsy biomarker for the diagnosis and prognosis of patients with pancreatic ductal adenocarcinoma. Int J Mol Sci. 26:15002025. View Article : Google Scholar : PubMed/NCBI | |
|
Fan Z, Yu J, Lin J, Liu Y and Liao Y: Exosome-specific tumor diagnosis via biomedical analysis of exosome-containing microRNA biomarkers. Analyst. 144:5856–5865. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Long Y, Wang X, Youmans DT and Cech TR: How do lncRNAs regulate transcription? Sci Adv. 3:eaao21102017. View Article : Google Scholar : PubMed/NCBI | |
|
Pandya G, Kirtonia A, Sethi G, Pandey AK and Garg M: The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential. Biochim Biophys Acta Rev Cancer. 1874:1884232020. View Article : Google Scholar : PubMed/NCBI | |
|
Lin H, Yu J, Gu X, Ge S and Fan X: Novel insights into exosomal circular RNAs: Redefining intercellular communication in cancer biology. Clin Transl Med. 11:e6362021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Q and Zhou T: Emerging functional principles of tRNA-derived small RNAs and other regulatory small RNAs. J Biol Chem. 299:1052252023. View Article : Google Scholar : PubMed/NCBI | |
|
Guo S, Wang X, Shan D, Xiao Y, Ju L, Zhang Y, Wang G and Qian K: The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA. Biomark Res. 12:1232024. View Article : Google Scholar : PubMed/NCBI | |
|
Makler A and Narayanan R: Mining exosomal genes for pancreatic cancer targets. Cancer Genomics Proteomics. 14:161–172. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Chiang CL, Kwak KJ, Wang X, Doddi S, Ramanathan LV, Cho SM, Hou YC, Cheng TS, Mo X, et al: Extracellular vesicular analysis of glypican 1 mRNA and protein for pancreatic cancer diagnosis and prognosis. Adv Sci (Weinh). 11:e23063732024. View Article : Google Scholar : PubMed/NCBI | |
|
Buscail E, Chauvet A, Quincy P, Degrandi O, Buscail C, Lamrissi I, Moranvillier I, Caumont C, Verdon S, Brisson A, et al: CD63-GPC1-positive exosomes coupled with CA19-9 offer good diagnostic potential for resectable pancreatic ductal adenocarcinoma. Transl Oncol. 12:1395–1403. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lai X, Wang M, McElyea SD, Sherman S, House M and Korc M: A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer. Cancer Lett. 393:86–93. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Skotland T, Hessvik NP, Sandvig K and Llorente A: Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res. 60:9–18. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma R, Huang X, Brekken RA and Schroit AJ: Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies. Br J Cancer. 117:545–552. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tao L, Zhou J, Yuan C, Zhang L, Li D, Si D, Xiu D and Zhong L: Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer. Metabolomics. 15:862019. View Article : Google Scholar : PubMed/NCBI | |
|
Tiankanon K, Pungpipattrakul N, Sukaram T, Chaiteerakij R and Rerknimitr R: Identification of breath volatile organic compounds to distinguish pancreatic adenocarcinoma, pancreatic cystic neoplasm, and patients without pancreatic lesions. World J Gastrointest Oncol. 16:894–906. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Pelling M, Chandrapalan S, West E and Arasaradnam RP: A systematic review and meta-analysis: Volatile organic compound analysis in the detection of hepatobiliary and pancreatic cancers. Cancers (Basel). 15:23082023. View Article : Google Scholar : PubMed/NCBI | |
|
Nagarajan Y, Chandrasekaran N and Deepa Parvathi V: Functionalized nanomaterials in pancreatic cancer theranostics and molecular imaging. ChemistryOpen. 14:e2024002322025. View Article : Google Scholar : PubMed/NCBI | |
|
Caputo D and Caracciolo G: Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma. Cancer Lett. 470:191–196. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yin X, He Z, Ge W and Zhao Z: Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors. Front Bioeng Biotechnol. 11:10929012023. View Article : Google Scholar : PubMed/NCBI | |
|
Moccia M, Caratelli V, Cinti S, Pede B, Avitabile C, Saviano M, Imbriani AL, Moscone D and Arduini F: Paper-based electrochemical peptide nucleic acid (PNA) biosensor for detection of miRNA-492: A pancreatic ductal adenocarcinoma biomarker. Biosens Bioelectron. 165:1123712020. View Article : Google Scholar : PubMed/NCBI | |
|
Carigga Gutierrez NM, Clainche TL, Bulin AL, Leo S, Kadri M, Abdelhamid AGA, Pujol-Solé N, Obaid G, Hograindleur MA, Gardette V, et al: Engineering radiocatalytic nanoliposomes with hydrophobic gold nanoclusters for radiotherapy enhancement. Adv Mater. 36:e24046052024. View Article : Google Scholar : PubMed/NCBI | |
|
Phua VJX, Yang CT, Xia B, Yan SX, Liu J, Aw SE, He T and Ng DCE: Nanomaterial probes for nuclear imaging. Nanomaterials (Basel). 12:5822022. View Article : Google Scholar : PubMed/NCBI | |
|
Kaczor-Urbanowicz KE, Cheng J, King JC, Sedarat A, Pandol SJ, Farrell JJ, Wong DTW and Kim Y: Reviews on current liquid biopsy for detection and management of pancreatic cancers. Pancreas. 49:1141–1152. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Qiao Z, Ge J, He W, Xu X and He J: Artificial intelligence algorithm-based computerized tomography image features combined with serum tumor markers for diagnosis of pancreatic cancer. Comput Math Methods Med. 2022:89794042022. View Article : Google Scholar : PubMed/NCBI |
